FimmCyte Company
FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
Industry:
Pelvic & Uterine Healthcare
Headquarters:
Basel, Basel-Stadt, Switzerland
Founded Date:
01-01-2022
Employees Number:
1-10
Investors Number:
3
Total Funding:
$1,350,764
Last Funding Date:
2022-07-13
Last Funding Type:
Grant
Register and Claim Ownership